Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CV Sciences (CVSI) Revenue (2016 - 2025)

CV Sciences' Revenue history spans 13 years, with the latest figure at $3.3 million for Q4 2025.

  • On a quarterly basis, Revenue fell 14.86% to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.8 million, a 12.2% decrease, with the full-year FY2025 number at $13.8 million, down 12.2% from a year prior.
  • Revenue hit $3.3 million in Q4 2025 for CV Sciences, up from $3.3 million in the prior quarter.
  • Over the last five years, Revenue for CVSI hit a ceiling of $5.1 million in Q2 2021 and a floor of $3.3 million in Q3 2025.
  • Historically, Revenue has averaged $4.1 million across 5 years, with a median of $4.0 million in 2023.
  • Biggest five-year swings in Revenue: plummeted 41.43% in 2021 and later grew 9.01% in 2023.
  • Tracing CVSI's Revenue over 5 years: stood at $5.0 million in 2021, then fell by 22.14% to $3.9 million in 2022, then decreased by 1.76% to $3.8 million in 2023, then increased by 2.18% to $3.9 million in 2024, then decreased by 14.86% to $3.3 million in 2025.
  • Business Quant data shows Revenue for CVSI at $3.3 million in Q4 2025, $3.3 million in Q3 2025, and $3.6 million in Q2 2025.